Anna has launched 13 products in oncology and rare diseases. She had direct P&L responsibility for global, European and individual country businesses. She built a successful European biotech business for a US-based company from scratch. Anna is responsible for Alacrita AG in Zug, Switzerland.
Anna focuses on commercialisation, particularly European launch. She manages the firm’s European office based in Zug, Switzerland, which offers a full cross-functional launch platform and operations for US companies wishing to enter the European market. She has expertise in oncology, haematology and rare diseases.
Recent projects she has conducted or directed include: